Table 1 Baseline characteristics
From: Application and comparison of different implanted ports in malignant tumor patients
Variable | Upper vein group | Jugular vein group | Subclavian vein group |
|---|---|---|---|
Patients | 107 | 70 | 167 |
Age (years) | 54.4 ± 12.3 | 53.8 ± 13.0 | 53.0 ± 13.3 |
Sex | |||
Male | 64 (59.8) | 41 (58.6) | 104 (62.3) |
Female | 43 (40.2) | 29 (41.4) | 63 (37.7) |
Primary tumor | |||
Colon cancer | 33 (30.8) | 31 (44.3) | 66 (39.5) |
Rectal cancer | 52 (48.6) | 31 (44.3) | 84 (50.3) |
Gastric cancer | 12 (11.2) | 7 (10.0) | 13 (7.8) |
Pancreatic cancer | 2 (1.9) | 1 (1.4) | 0 (0) |
Small intestinal carcinoma | 1 (0.9) | 0 (0) | 0 (0) |
Esophageal cancer | 1 (0.9) | 0 (0) | 3 (1.8) |
Bile duct carcinoma | 1 (0.9) | 0 (0) | 0 (0) |
Hepatic carcinoma | 1 (0.9) | 0 (0) | 0 (0) |
Others | 4 (3.7) | 0 (0) | 1 (0.6) |
Follow-up duration (days) | 257.6 ± 134.1 | 307.9 ± 134.3 | 253.4 ± 152.8 |